medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • Policies
    • Políticas éticas
    • Políticas editoriales generales
    • Políticas de revisión de manuscritos
    • Políticas de acceso abierto
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number 2

<< Back Next >>

Rev Mex Pediatr 2026; 93 (2)

Diagnosis of neonatal hemochromatosis through fundus examination

Rivera-Comparán EA, Rodríguez-Páez IV, Peregrino-Bejarano L, Siordia-Reyes G, Vázquez-Lara Y
Full text How to cite this article 10.35366/123612

DOI

DOI: 10.35366/123612
URL: https://dx.doi.org/10.35366/123612

Language: Spanish
References: 15
Page: 77-81
PDF size: 1916.71 Kb.


Key words:

hemochromatosis, fundus examination, cirrhosis, iron deposits, infant, autopsy.

ABSTRACT

Introduction: neonatal hemochromatosis (NH) is a rare disease characterized by severe liver damage secondary to gestational alloimmune liver disease. The diagnosis of NH requires the demonstration of extrahepatic hemosiderosis by biopsy or imaging studies. Objective: to present a patient with NH in order to improve the identification of similar cases and to propose fundus examination as part of the diagnostic process, as an alternative for detecting iron deposits in the retina. Clinical case: a four-month-old female patient with hypoglycemia since birth, who progressed to failure to thrive, hepatomegaly, ascites, coagulopathy, thrombocytopenia, and hyperferritinemia. Fundus examination revealed pigmentary changes localized in the macular area and in the equatorial and peripheral retina of both eyes. The patient died of septic shock. Autopsy revealed hepatic cirrhosis with ductal proliferation, cholestasis, and hemosiderosis, as well as iron deposits in the spleen and pancreas. Conclusions: fundus examination is a non-invasive method that can contribute to the early diagnosis of NH.


REFERENCES

  1. Sandoval-Garín N, Zarate-Mondragón FE. Actualización en la hemocromatosis neonatal. Acta Pediatr Mex. 2021; 42(6): 294-304.

  2. Ayala SK, Ríos DM, Mondragón FZ, Montijo-Barrios E, Cervantes-Bustamante R, Alfonso J et al. Hepatitis fulminante secundaria a hemocromatosis neonatal, diagnósticos diferenciales: reporte de un caso y revisión de la literatura. Rev Latin Infect Pediatr. 2017; 30(1): 32-36. Available from: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=72412

  3. Grabhorn E, Richter A, Burdelski M, Rogiers X, Ganschow R. Neonatal hemochromatosis: long-term experience with favorable outcome. Pediatrics. 2006; 118(5): 2060-2065.

  4. Rodríguez A, Ramón G, Tejeda S, Siordia GA, Ferman F, Cantú M. Hemocromatosis neonatal. Informe de tres casos de autopsia. Rev Invest Clin. 1999; 51(2): 81-87.

  5. Arias-Agudelo LM, Mesa-Arango JA, Franco-Alzate C, Santiago-Pacheco V. Hemocromatosis: actualización clínica y diagnóstica. Med Lab. 2023; 27(3): 229-244.

  6. Casas-Alba D, Clotet J, Inarejos EJ, Jou C, Fons C, Molera C. Broadening the spectrum of neonatal hemochromatosis. J Matern Fetal Neonatal Med. 2020; 33(6): 1024-1026.

  7. Staicu A, Popa-Stanila R, Albu C, Chira A, Constantin R, Boitor-Borza D et al. Neonatal hemochromatosis: systematic review of prenatal ultrasound findings—Is there a place for MRI in the diagnostic process? J Clin Med. 2023; 12(7): 2679.

  8. Molera-Busoms C, Quintero-Bernabeu J, Martín-de Carpi J. Neonatal hemochromatosis: another entity that is no longer orphan. Advances in the diagnosis and management of the main cause of neonatal acute liver failure. An Pediatr (Engl Ed). 2015; 83(3): 218.e1-218.e3. Available from: https://www.sciencedirect.com/science/article/abs/pii/S2341287915001465

  9. Bastos KL de M, Quaio CR, Lima FR, Araújo IM, Araújo CAT, Piazzon FB, et al. Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation. Clin Mol Hepatol. 2019; 25(1): 86-91.

  10. Bellsmith KN, Dunaief JL, Yang P, Pennesi ME, Davis E, Hofkamp H et al. Bull's eye maculopathy associated with hereditary hemochromatosis. Am J Ophthalmol Case Rep. 2020; 18: 100674.

  11. Cruceyra M, Martínez N, de la Calle M, González M, Viejo A, Frauca E et al. Nueva terapia con inmunoglobulinas en un caso de hemocromatosis neonatal. Rev Chil Obstet Ginecol. 2010; 75(3): 204-206.

  12. Guevara Y, Vela M, Juárez J, Ordaz J, Belmont L. Manifestaciones oftalmológicas de los errores innatos del metabolismo. Acta Pediatr Mex. 2013; 34(4): 212-224.

  13. Mugarab-Samedi V, Ryan MD, Awad EH Al, Elsharkawy A. The effect of prenatal and postnatal treatment with intravenous immunoglobulin on severity of neonatal hemochromatosis: the tale of two brothers (case report). AJP Rep. 2021; 11(2): e102-e104.

  14. Zhang H, Li Q, Zhao C, Yang Z. A rare case of neonatal hemochromatosis. Asian J Surg. 2023; 46(8): 3142-3143. Disponible en: https://www.sciencedirect.com/science/article/pii/S101595842300266X?via%3Dihub

  15. Feldman AG, Whitington PF. Neonatal hemochromatosis. J Clin Exp Hepatol. 2013; 3(4): 313-320.




Figure 1
Figure 2
Figure 3
Figure 4
CC BY-NC-ND

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2026;93